SIGNUM SURGICAL LIMITED

Signum Surgical Limited is a medical‑technology company dedicated to improving outcomes for patients suffering from anal fistula. Drawing on extensive research, the firm has created BioHealx®, a minimally invasive, tissue‑apposition system that enables primary fistula healing while preserving the anal sphincter. By closing the fistula in a single procedure, BioHealx reduces pain, lowers recurrence rates and minimises the risk of permanent incontinence – a common drawback of existing treatments.

The company’s focus is on delivering a solution that enhances quality of life for those burdened by chronic discharge, pain and repeated surgeries. BioHealx is designed for use by colorectal surgeons and specialist centres seeking a reliable, single‑step approach that streamlines the operative process and accelerates patient recovery. With an emphasis on safety, efficacy and patient‑centred care, Signum Surgical positions itself as a forward‑thinking partner for clinicians aiming to offer better, less invasive options for fistula management.